Douglas R. Lowy
Co-developed the HPV vaccine technology that is eliminating cervical cancer in vaccinated populations.
With John Schiller, developed the virus-like particle approach underlying all licensed HPV vaccines (Lasker Award 2017); has served as acting and principal deputy director of NCI.
Pages like this
not linked directly; found by shared links- TrialKEN SHE (single-dose HPV vaccine)
Shares Ian Frazer, Nonavalent HPV vaccine, HPV & HBV vaccination, Cervical cancer.
- PersonJian Zhou
Shares Ian Frazer, Nonavalent HPV vaccine, HPV & HBV vaccination, Cervical cancer.
- PersonDenise A. Galloway
Shares Ian Frazer, HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
- PersonHarald zur Hausen
Shares Ian Frazer, Nonavalent HPV vaccine, HPV & HBV vaccination, Cervical cancer.
- IdeaCommunity-tailored HPV vaccine confidence campaigns with school-based delivery
Shares HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
- IdeaEliminate infection-caused cancers: HPV, hepatitis B and C, H. pylori and EBV
Shares HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
- IdeaSwitch every country to single-dose HPV vaccination and add catch-up to age 26
Shares HPV & HBV vaccination, Cervical cancer, Head and neck squamous cell carcinoma.
- IdeaSingle-dose HPV vaccination plus HPV self-sampling to reach WHO elimination in low-income countries
Shares Nonavalent HPV vaccine, HPV & HBV vaccination, Cervical cancer.